225 related articles for article (PubMed ID: 23152267)
21. Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.
Yancy CW; Fowler MB; Colucci WS; Gilbert EM; Bristow MR; Cohn JN; Lukas MA; Young ST; Packer M;
N Engl J Med; 2001 May; 344(18):1358-65. PubMed ID: 11333992
[TBL] [Abstract][Full Text] [Related]
22. The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy.
Pimentel Wde S; Ramires FJ; Lanni BM; Salemi VM; Bilate AM; Cunha-Neto E; Oliveira AM; Fernandes F; Mady C
Clinics (Sao Paulo); 2012 Sep; 67(9):1063-9. PubMed ID: 23018305
[TBL] [Abstract][Full Text] [Related]
23. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients.
Ngo K; Kotecha D; Walters JA; Manzano L; Palazzuoli A; van Veldhuisen DJ; Flather M
Cochrane Database Syst Rev; 2010 Jan; (1):CD007613. PubMed ID: 20091643
[TBL] [Abstract][Full Text] [Related]
24. Beta-Blockers (Carvedilol) in Children with Systemic Ventricle Systolic Dysfunction - Systematic Review and Meta-Analysis.
Prijic S; Buchhorn R; Kosutic J; Vukomanovic V; Prijic A; Bjelakovic B; Zdravkovic M
Rev Recent Clin Trials; 2014; 9(2):68-75. PubMed ID: 25198735
[TBL] [Abstract][Full Text] [Related]
25. Diuretics for heart failure.
Faris RF; Flather M; Purcell H; Poole-Wilson PA; Coats AJ
Cochrane Database Syst Rev; 2012 Feb; (2):CD003838. PubMed ID: 22336795
[TBL] [Abstract][Full Text] [Related]
26. Diuretics for heart failure.
Faris R; Flather MD; Purcell H; Poole-Wilson PA; Coats AJ
Cochrane Database Syst Rev; 2006 Jan; (1):CD003838. PubMed ID: 16437464
[TBL] [Abstract][Full Text] [Related]
27. Homocysteine lowering interventions for preventing cardiovascular events.
Martí-Carvajal AJ; Solà I; Lathyris D; Salanti G
Cochrane Database Syst Rev; 2009 Oct; (4):CD006612. PubMed ID: 19821378
[TBL] [Abstract][Full Text] [Related]
28. Hawthorn extract for treating chronic heart failure.
Pittler MH; Guo R; Ernst E
Cochrane Database Syst Rev; 2008 Jan; (1):CD005312. PubMed ID: 18254076
[TBL] [Abstract][Full Text] [Related]
29. Cost effectiveness of carvedilol for heart failure.
Delea TE; Vera-Llonch M; Richner RE; Fowler MB; Oster G
Am J Cardiol; 1999 Mar; 83(6):890-6. PubMed ID: 10190405
[TBL] [Abstract][Full Text] [Related]
30. Digitalis for treatment of heart failure in patients in sinus rhythm.
Hood WB; Dans AL; Guyatt GH; Jaeschke R; McMurray JJ
Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD002901. PubMed ID: 24771511
[TBL] [Abstract][Full Text] [Related]
31. Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis.
Chadalawada S; Rassi A; Samara O; Monzon A; Gudapati D; Vargas Barahona L; Hyson P; Sillau S; Mestroni L; Taylor M; da Consolação Vieira Moreira M; DeSanto K; Agudelo Higuita NI; Franco-Paredes C; Henao-Martínez AF
ESC Heart Fail; 2021 Dec; 8(6):5466-5481. PubMed ID: 34716744
[TBL] [Abstract][Full Text] [Related]
32. Beta-blockers in heart failure. Future directions.
Sharpe N
Eur Heart J; 1996 Apr; 17 Suppl B():39-42. PubMed ID: 8733070
[TBL] [Abstract][Full Text] [Related]
33. Human recombinant activated protein C for severe sepsis.
Martí-Carvajal AJ; Solà I; Lathyris D; Cardona AF
Cochrane Database Syst Rev; 2011 Apr; (4):CD004388. PubMed ID: 21491390
[TBL] [Abstract][Full Text] [Related]
34. Carvedilol in dogs with dilated cardiomyopathy.
Oyama MA; Sisson DD; Prosek R; Bulmer BJ; Luethy MW; Fuentes VL
J Vet Intern Med; 2007; 21(6):1272-9. PubMed ID: 18196737
[TBL] [Abstract][Full Text] [Related]
35. Does intention-to-treat analysis answer all questions in long-term mortality trials? Considerations on the basis of the ANZ trial.
Tillmann HC; Sharpe N; Sponer G; Wehling M
Int J Clin Pharmacol Ther; 2001 May; 39(5):205-12. PubMed ID: 11380066
[TBL] [Abstract][Full Text] [Related]
36. Human recombinant activated protein C for severe sepsis.
Martí-Carvajal A; Salanti G; Cardona AF
Cochrane Database Syst Rev; 2008 Jan; (1):CD004388. PubMed ID: 18254048
[TBL] [Abstract][Full Text] [Related]
37. Measurement of clinical efficacy in studies of heart failure.
Rector TS
Circulation; 1998 Feb; 97(7):707. PubMed ID: 9495309
[No Abstract] [Full Text] [Related]
38. Interventions for treating peripartum cardiomyopathy to improve outcomes for women and babies.
Carlin AJ; Alfirevic Z; Gyte GM
Cochrane Database Syst Rev; 2010 Sep; (9):CD008589. PubMed ID: 20824881
[TBL] [Abstract][Full Text] [Related]
39. Amiodarone for arrhythmia in patients with Chagas disease: A systematic review and individual patient data meta-analysis.
Stein C; Migliavaca CB; Colpani V; da Rosa PR; Sganzerla D; Giordani NE; Miguel SRPS; Cruz LN; Polanczyk CA; Ribeiro ALP; Falavigna M
PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006742. PubMed ID: 30125291
[TBL] [Abstract][Full Text] [Related]
40. Digoxin serum levels in patients with Chagas' cardiomyopathy and heart failure.
Ferrari SJ; Bestetti RB; Cardinalli-Neto A; Bortoluzzi TB
Rev Soc Bras Med Trop; 2010; 43(5):496-9. PubMed ID: 21085856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
